Market Place
Sourcing Support
All News #Library
Generics
Breckenridge Launches Milnacipran Hcl Tablets, Generic Version
20 Mar 2026 //
PR NEWSWIRE
Breckenridge Launches Pomalidomide Capsules
03 Mar 2026 //
PRESS RELEASE
Breckenridge Launches 1mg Everolimus Tablets, Generic Zortress
30 Oct 2025 //
PR NEWSWIRE
Breckenridge Gets FDA Nod for Dehydrated Alcohol Injection
24 Jun 2025 //
PR NEWSWIRE
Breckenridge Receives FDA Approval for Methadone HCl Injection
18 Dec 2024 //
PR NEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules
13 Nov 2020 //
PRNEWSWIRE
Pomalyst (Pomalidomide) : Celgene Corp. vs. Breckenridge Pharma
19 Oct 2018 //
PATENT LITIGATION
Breckenridge Announces Final ANDA Approval of Roflumilast Tablets
06 Oct 2018 //
PR NEWSWIRE
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Kyprolis® (Carfilzomib):Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical
16 Feb 2018 //
PATENT LITIGATION
Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.
05 May 2017 //
PRESS RELEASE
Afinitor (Everolimus): Novartis v. Breckenridge Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Breckenridge Pharmaceutical
05 Apr 2017 //
PATENT LITIGATION
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.